loadpatents
Patent applications and USPTO patent grants for Laquerre; Sylvie.The latest application filed is for "proteins comprising hla-g antigen binding domains and their uses".
Patent | Date |
---|---|
Proteins Comprising Hla-g Antigen Binding Domains And Their Uses App 20220033505 - Obermajer; Natasa ;   et al. | 2022-02-03 |
Treatment of Patients Having c-Met Exon 14 Skipping Mutations App 20210253717 - Knoblauch; Roland ;   et al. | 2021-08-19 |
Multispecific Binding Molecules Comprising Ltbr And Edb Binding Domains And Uses Thereof App 20210188990 - LORENZI; Matthew ;   et al. | 2021-06-24 |
Method of Adjuvant Cancer Treatment App 20210060021 - Laquerre; Sylvie ;   et al. | 2021-03-04 |
Combination Therapies With Bispecific Anti-EGFR/c-Met Antibodies and Third Generation EGFR Tyrosine Kinase Inhibitors App 20210017285 - Laquerre; Sylvie ;   et al. | 2021-01-21 |
Method of adjuvant cancer treatment Grant 10,869,869 - Laquerre , et al. December 22, 2 | 2020-12-22 |
Method of Adjuvant Cancer Treatment App 20200054641 - Laquerre; Sylvie ;   et al. | 2020-02-20 |
Method of Adjuvant Cancer Treatment App 20180338979 - Laquerre; Sylvie ;   et al. | 2018-11-29 |
Combination App 20180214451 - Dumble; Melissa ;   et al. | 2018-08-02 |
Cyclic Dinucleotides As Sting Agonists App 20180162899 - Bignan; Gilles ;   et al. | 2018-06-14 |
Method of Adjuvant Cancer Treatment App 20170202842 - Laquerre; Sylvie ;   et al. | 2017-07-20 |
Combination App 20170065593 - Gilmer; Tona Morgan ;   et al. | 2017-03-09 |
Combination of inhibitor of B-Raf and inhibitor of AKT in the treatment of cancer Grant 9,402,846 - Dumble , et al. August 2, 2 | 2016-08-02 |
Combination App 20160143913 - Dumble; Melissa ;   et al. | 2016-05-26 |
Combination App 20160008368 - Gilmer; Tona ;   et al. | 2016-01-14 |
Method of Adjuvant Cancer Treatment App 20150216868 - Laquerre; Sylvie ;   et al. | 2015-08-06 |
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses Grant 9,067,873 - Deng , et al. June 30, 2 | 2015-06-30 |
Method Of Treating Cancer With MEGEA3 Immunotherapeutic With BRAF Inhibitor And/Or MEK Inhibitor App 20150147350 - Gerard; Catherine Marie Ghislaine ;   et al. | 2015-05-28 |
Pharmaceutical Combination Of Mek Inhibitor And B-raf Inhibitors App 20150111904 - Dumble; Melissa ;   et al. | 2015-04-23 |
Combination App 20150094321 - DUMBLE; Melissa ;   et al. | 2015-04-02 |
Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases Grant 8,962,667 - Nitz , et al. February 24, 2 | 2015-02-24 |
Pharmaceutical combination of MEK inhibitor and B-Raf inhibitors Grant 8,952,018 - Dumble , et al. February 10, 2 | 2015-02-10 |
Compounds, Compositions And Methods For Treating Or Preventing Pneumovirus Infection And Associated Diseases App 20140363395 - Nitz; Theodore J. ;   et al. | 2014-12-11 |
Combination App 20140350039 - DUMBLE; Melissa ;   et al. | 2014-11-27 |
Combination App 20140309243 - DUMBLE; Melissa ;   et al. | 2014-10-16 |
Combination App 20140303195 - GILMER; Tona ;   et al. | 2014-10-09 |
Sulfonyl Semicarbazides, Semicarbazides And Ureas, Pharmaceutical Compositions Thereof, And Methods For Treating Hemorrhagic Fever Viruses, Including Infections Associated With Arenaviruses App 20140275037 - Deng; Yijun ;   et al. | 2014-09-18 |
Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancer Grant 8,835,450 - Dumble , et al. September 16, 2 | 2014-09-16 |
Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfo- namide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarbo Grant 8,796,298 - Dumble , et al. August 5, 2 | 2014-08-05 |
Pharmaceutical Combination Of Mek Inhibitor And B-raf Inhibitors App 20140187566 - Dumble; Melissa ;   et al. | 2014-07-03 |
Pharmaceutical combination of MEK inhibitor and B-RAF inhibitors Grant 8,703,781 - Dumble , et al. April 22, 2 | 2014-04-22 |
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses Grant 8,642,596 - Deng , et al. February 4, 2 | 2014-02-04 |
Methods For Treating Cancer App 20130217710 - Alves-Aivado; Manuel Carlos ;   et al. | 2013-08-22 |
Combination App 20120322817 - Dumble; Melissa ;   et al. | 2012-12-20 |
Combination App 20120283279 - Gilmer; Tona ;   et al. | 2012-11-08 |
Combination App 20120283278 - Dumble; Melissa ;   et al. | 2012-11-08 |
Combination App 20120245180 - Auger; Kurt R. ;   et al. | 2012-09-27 |
Combination App 20120202822 - Bachman; Kurtis Earl ;   et al. | 2012-08-09 |
Combination App 20120202835 - Dumble; Melissa ;   et al. | 2012-08-09 |
Combination App 20120196886 - Dumble; Melissa ;   et al. | 2012-08-02 |
Pharmaceutical Combination of MEK Inhibitor and B-RAF Inhibitors App 20120196879 - Dumble; Melissa ;   et al. | 2012-08-02 |
Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arena Viruses App 20090203675 - Deng; Yijun ;   et al. | 2009-08-13 |
Nucleic acids encoding Candida kefyr cytosine deaminase Grant 7,556,955 - Shen , et al. July 7, 2 | 2009-07-07 |
Antibody that specifically binds to Candida kefyr Cytosine deaminase Grant 7,414,113 - Shen , et al. August 19, 2 | 2008-08-19 |
Oncolytic adenovirus Grant 7,396,679 - Johnson , et al. July 8, 2 | 2008-07-08 |
Candida Kefyr Cytosine Deaminase App 20070026491 - Shen; Yuqiao ;   et al. | 2007-02-01 |
Candida Kefyr Cytosine Deaminase App 20060286592 - Shen; Yuqiao ;   et al. | 2006-12-21 |
Candida kefyr cytosine deaminase Grant 7,141,404 - Shen , et al. November 28, 2 | 2006-11-28 |
Oncolytic adenovirus Grant 7,078,030 - Johnson , et al. July 18, 2 | 2006-07-18 |
Oncolytic adenovirus App 20040241142 - Johnson, Leisa ;   et al. | 2004-12-02 |
Candida kefyr cytosine deaminase App 20040180418 - Shen, Yuqiao ;   et al. | 2004-09-16 |
Oncolytic adenovirus App 20040151696 - Johnson, Leisa ;   et al. | 2004-08-05 |
Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growth Grant 6,723,316 - Laquerre , et al. April 20, 2 | 2004-04-20 |
Herpes simplex virus for treating unwanted hyperproliferative cell growth Grant 6,660,259 - Laquerre , et al. December 9, 2 | 2003-12-09 |
Herpes simplex virus for treating unwanted hyperproliferative cell growth App 20020072119 - Laquerre, Sylvie ;   et al. | 2002-06-13 |
Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growth App 20020054885 - Laquerre, Sylvie ;   et al. | 2002-05-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.